EBV-positive lymphoproliferative disease with medullary, splenic and hepatic infiltration after imatinib mesylate therapy for chronic myeloid leukemia.

Thibaut Leguay,Carine Foucaud,Marie Parrens,O. Fitoussi,Kamal Bouabdallah,Marc-Antoine Belaud-Rotureau,Reza Tabrizi,Gerald Marit,A Pigneux,N. Milpied

EBV-positive lymphoproliferative disease with medullary, splenic and hepatic infiltration after imatinib mesylate therapy for chronic myeloid leukemia.

2007

Thibaut Leguay
Carine Foucaud
Marie Parrens
O. Fitoussi
Kamal Bouabdallah
Marc-Antoine Belaud-Rotureau
Reza Tabrizi
Gerald Marit
A Pigneux
N. Milpied

EBV-positive lymphoproliferative disease with medullary, splenic and hepatic infiltration after imatinib mesylate therapy for chronic myeloid leukemia

Keywords:

EBV Positive
Lymphoproliferative disease
Cancer research
Mesylate
Myeloid leukemia
Medullary cavity
Imatinib
Pathology
Diabetes mellitus
Biology
imatinib mesylate

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations